| Autor: |
van der Horst HJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Oostindie SC; Genmab, Utrecht, the Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, the Netherlands., Cillessen SAGM; Department of Clinical Pathology, Amsterdam UMC, Amsterdam, the Netherlands., Gelderloos AT; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Overdijk MB; Genmab, Utrecht, the Netherlands., Nijhof IS; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Chamuleau MED; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Breij ECW; Genmab, Utrecht, the Netherlands., Mutis T; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. |
Plný text